Drug Discovery Market Research Reports & Industry Analysis
Drug discovery is the systematic process of identifying, designing, and developing new pharmaceutical compounds or therapies to treat specific diseases or medical conditions. This is a high-cost, risky business because only a fraction of the therapeutic targets selected for study will yield products that achieve regulatory approval by the Food & Drug Administration (FDA). To help stakeholders navigate this complex market, MarketResearch.com offers a suite of comprehensive drug discovery reports on industries big and small.
Understanding the Drug Discovery Market
- Our compilation of reports features thousands of reports from leading research firms, allowing you to access highly targeted information.
- We provide a rich repository of data, including analysis of drug discovery market trends, forecasts, growth opportunities, and strategies.
- We also provide expert commentary on disruptive technologies and the use of artificial intelligence, machine learning, and blockchain in drug discovery.
Informed Insights: Your Path to Success
Whether you're an industry professional, a consultant, or an executive, our research collection provides credible data to help you make informed decisions that catalyze growth. For decades, we have served top pharmaceutical companies, investment banks, and consulting firms as a trusted research partner. Uncover new opportunities and stay ahead of the curve with MarketResearch.com's drug discovery industry reports.
Drug Discovery Industry Research & Market Reports
-
How AI and ML Are Fueling Drug Discovery: Taking Compute and Storage to the Next Level
... drug discovery. It dwells upon some of the infrastructural challenges and complexities (including compute and storage) that the industry has been facing, provides an insight into the burgeoning and diverse market landscape of players both ... Read More
-
Alzheimer’s Therapeutics Market
... a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the Alzheimer’s therapeutics market, the growth prospects of the market are obtained ... Read More
-
Alopecia Areata Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 36 million prevalent cases of lopecia areata across 16 pharmaceutical markets. No FDA-approved marketed drugs are available for Alopecia areata; however, there are several treatments used off-label to ... Read More
-
Metabolomics Services Market, 2022-2035
... 30% of the known genetic disorders are associated with small-molecule metabolism. Therefore, metabolome profiling can assist in obtaining a better understanding of the disease. The approach has also demonstrated to be capable of identifying new ... Read More
-
Pancreatic Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... In 2022, there will be more than 158,442 diagnosed prevalent cases of pancreatic cancer across 16 pharmaceutical markets. There are five leading marketed drugs for the treatment of pancreatic cancer, AstraZeneca is a key player ... Read More
-
Human Microbiome Market by Product (Prebiotics, Probiotics, Food, Diagnostic Tests, Drugs), Application (Therapeutic, Diagnostic), Disease (Infectious, Metabolic/Endocrine), Research Technology (Genomics, Proteomics, Metabolomics) - Global Forecast to 2029
... USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus ... Read More
-
Artificial Intelligence In Drug Discovery Market Size, Share & Trends Analysis Report By Application (Drug Optimization & Repurposing, Preclinical Testing), By Therapeutic Area, By Region, And Segment Forecasts, 2022 - 2030
... Discovery Market Growth & Trends The global artificial intelligence in drug discovery market size is expected to reach USD 9.1 billion by 2030, according to a new report by Grand View Research, Inc. It is ... Read More
-
CRO Mass Spectroscopy Services Market Size By Service Type (Proteomics Services, Metabolomics Services), By End-use (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2022 - 2028
... Forecast, 2022 - 2028 The CRO mass spectroscopy services market is expected to grow significantly by 2028 on account of technological advancements in spectrometers to deliver high-resolution results. In addition, rising concerns regarding food safety ... Read More
-
ATP Assays Market by Product (Consumables (Kits, Reagent, Microplate), Instrument (Luminometer, Spectrophotometers)), Application (Contamination, Disease Testing, Drug Discovery), End User (Hospitals, Pharmaceuticals, Food Testing) - Global Forecast to 2027
... projected to reach USD 412 million by 2027 from USD 276 million in 2022, at a CAGR of 8.4%. The growth of this market can largely be attributed to the increasing food safety concerns, growing ... Read More
-
Small Cell Lung Cancer Marketed and Pipeline Drugs Assessment, Clinical Trials, Social Media and Competitive Landscape, 2022 Update
... Lung Cancer therapeutics. Synopsis In 2022, there will be more than 210,000 diagnosed prevalent cases of SCLC across 16 pharmaceutical markets. There are three leading marketed drugs for the treatment of SCLC, AstraZeneca is a ... Read More
-
Global Cancer Supportive Care Drugs Market 2022-2028
... management of physical and psychological symptoms and side-effects across the continuum of the cancer experience from diagnosis through anticancer treatment to post-treatment care. The market for cancer supportive care drugs worldwide is expected to reach ... Read More
-
Leading Cystic Fibrosis Therapeutics Distribution Channel Markets Databank
... from 2021 to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. ... Read More
-
North America Cystic Fibrosis Therapeutics Market Databank
... 2021 to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail ... Read More
-
Central America (Costa Rica, Panama, Guatemala, Dominican Republic) Acute Myeloid Leukemia Drugs Market
... 5.5% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2020, the base year of calculation is 2021 and the forecast period is 2022 to 2029. ... Read More
-
Global Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
2022 Global Drug Discovery Services Industry (2028 Outlook)
... Market Outlook reports provide market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include the total ... Read More
-
Asia-Pacific Onychomycosis Treatment Market Databank
... 2021 to 2029. Drug treatment segment is expected to be the highest contributor to this market, with $2,435.6 Million in 2020, and is anticipated to reach $6,460.7 Million by 2029, registering a CAGR of 11.51%. Read More
-
2022 Global Biosimulation Industry (2028 Outlook)
... market size data for a three-year historical trend (2016-2019), a three-year forecast estimate trends (2020-2023), and a five-year outlook projection (2023-2028) for 46 countries. Market and product shipments include the total value of all products ... Read More
-
Global Structural Bioinformatics Market, By Product & Services (Tools, Platforms, Databases & Software), By Macromolecule (Proteins, RNA, DNA), By Application (Drug Discovery, X-ray Crystallography, NMR Spectroscopy, Others), By End User (Institutional Research v/s Industrial Research), By Region, Competition Forecast and Opportunities, 2017-2027
... By Region, Competition Forecast and Opportunities, 2017-2027 The global structural bioinformatics market is expected to grow at a significant rate during the forecast period. The market growth can be attributed to the rising demand for ... Read More
-
Cancer Therapy - Market Insights, Competitive Landscape and Market Forecast–2026
... Cancers, And Others), By End User (Hospitals, Specialty Clinics, And Others), and by geography is expected to advance at a respectable CAGR forecast till 2026 owing to rising prevalence of various cancers such as lung ... Read More
-
Europe Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Leading Cystic Fibrosis Therapeutics Country Markets Databank
... 2021 to 2029. Asia-Pacific is expected to be the highest contributor to this market, with $3,196.0 Million in 2020, and is anticipated to reach $4,216.6 Million by 2029, registering a CAGR of 3.16%. Asia-Pacific and ... Read More
-
Asia-Pacific Cystic Fibrosis Therapeutics Market Databank
... to 2029. Hospital segment is expected to be the highest contributor to this market, with $3,622.8 Million in 2020, and is anticipated to reach $4,436.7 Million by 2029, registering a CAGR of 2.32%. Retail pharmacies ... Read More
-
Leading Cystic Fibrosis Therapeutics Treatment Markets Databank
... 2021 to 2029. Route of Administration segment is expected to be the highest contributor to this market, with $2,818.1 Million in 2020, and is anticipated to reach $3,481.8 Million by 2029, registering a CAGR of ... Read More
-
Big Data in Pharmaceuticals - Thematic Research
... industries generate data in abundance from a multitude of sources including physician notes, pathology reports, electronic health records (EHR), patient registries, genomics, clinical trials, social media, wearable devices, and many more. The dataset in question ... Read More
Research Assistance
